Parkinson's disease (PD) is associated with a loss of central dopaminergic pathways in the brain leading to an abnormality of movement, including saccades. In PD, analysis of saccadic latency distributions, rather than mean latencies, can provide much more information about how the neural decision process that precedes movement is aVected by disease or medication. Subject to the constraints of intersubject variation and reproducibility, latency distribution may represent an attractive potential biomarker of PD. Here we report two studies that provide information about these parameters, and demonstrate a novel eVect of dopamine on saccadic latency, implying that it inXuences the neural decision process itself. We performed a detailed cross-sectional study of saccadic latency distributions during a simple step task in 22 medicated patients and 27 age-matched controls. This revealed high intersubject variability and an overlap of PD and control distributions. A second study was undertaken on a diVerent population speciWcally to investigate the eVects of dopamine on saccadic latency distributions in 15 PD patients. L-dopa was found to prolong latency, although the magnitude of the eVect varied between subjects. The implications of these observations for the use of saccadic latency distributions as a potential biomarker of PD are discussed, as are the eVects of L-dopa on neural decision making, where it is postulated to increase the criterion level of evidence required before the decision to move is made.
Introduction
Parkinson's disease (PD) is common, aVecting approximately 2% of the population over the age of 70, and causing an abnormality of movement, including saccades. Great eVorts are being made to develop neuroprotective treatments (Stocchi and Olanow 2003) , but it is increasingly recognised as a heterogeneous disease that can be diYcult to diagnose (Hughes et al. 1992 ; Lewis et al. 2005) . Thus accurate biomarkers of the disease would be extremely useful-ideally they should be reproducible, be able to separate disease and control populations, and track disease progression-but no single biomarker will be able to do it all, and therefore a range of approaches is necessary (discussed in Michell et al. 2004) . Of course, an ideal biomarker should be more than a surrogate marker, and should provide us with new information about how the brain functions in disease.
Saccadic eye movements have quite frequently been investigated as a potential biomarker of PD since they have a highly reproducible trajectory (Roy-Byrne et al. 1995) , and there is evidence that they might be aVected by cognitive decline, depression or other aspects of the disease (Leigh and Kennard 2004; Mosimann et al. 2005; Briand et al. 1999; Hikosaka et al. 2000) . However, these studies are not easy to compare given the diVerent target populations (early or advanced disease, medication eVects), testing paradigms used (gap or overlap of stimuli, 'reXexive' or 'voluntary' task) and parameters of the saccade measured (velocity, amplitude, duration, errors) .
The current investigation consisted of two parts: a cross-sectional study comparing a heterogeneous population with PD to controls, and an 'on/oV' L-dopa study conducted on a separate group of patients. From the biomarker perspective our aim was to investigate the intersubject variability in the latency distributions, and to assess the eVect of L-dopa on these measures and their reproducibility. Our second aim was to use data from the 'on/oV' study to help understand the eVects of dopamine on the brain's decision process that precedes movement . In this respect it is important to note that the model of decision making used here to interpret our observations is not limited to saccadic latency, but appears to be applicable across modalities (for example, auditory or manual reaction time) and species, and thus to motor control in general-which is clearly abnormal in PD (Carpenter 1999) .
This study diVers from those published to date in that we systematically analyse unusually large latency distributions rather than use a single statistic such as mean and variance. This distributional analysis then allows one to focus on the largely cortical factors that inXuence the neural decision to move, as opposed to those parameters (velocity and amplitude) of the movement itself, which are very stereotyped and essentially determined in the brainstem (Carpenter 2000) . The shape of the distribution of saccadic latencies can best be represented on a reciprobit plot (see Methods), which allows interpretation with reference to a quantitative model of the decision process that precedes movement (Carpenter 1981; Reddi et al. 2003) . Consequently, the measurement of latency distributions (rather than mean latency) has appeal not only as a biomarker (possibly of the failing motor decision mechanism or dementia), but also as a tool with which to study the brain's decision process and the inXuence of drugs upon this. Thus this study was not so much designed to develop a diagnostic biomarker of PD, as to begin characterising latency distributions in PD as a potential biomarker, and to determine the eVects of L-dopa on the decision process.
Thus the main diVerences in the approach we have adopted in these studies is that we have Wrst of all analysed latency distribution, using an explicit model of the underlying decision process. Secondly, the use of a newly developed miniaturised saccadometer enabled us to collect particularly large sets of data, which are necessary when distributions are analysed because of the great intrinsic variability of latency. Thirdly, because saccadic velocity and duration are highly reproducible, determined in the brainstem (low in the hierarchy of motor control, away from any decision process), and have been studied many times before, they were not recorded here. Finally, in order to hasten the collection of data, we used a relatively simple task: saccades are often conceptually divided into 'reXexive' or 'voluntary' categories depending on the complexity of task required to generate them (Leigh and Kennard 2004) , and in these terms our simple step task would be considered 'reXexive'. However, the task requires a decision (albeit perhaps subconscious) of when to move and in which direction to go, and this prolongs reaction time from about 70 ms (the shortest reXex arc via the superior colliculus) to nearer 200 ms. It is this procrastination, or decision, that we have investigated. While it is acknowledged that more complex 'voluntary' saccades (for example, antisaccades or memory-guided saccades) may permit a better separation of PD and control groups, such paradigms were not chosen here in the interests of speed and simplicity.
Our Wndings are discussed under two headings. Firstly, the intersubject variability, ability to separate PD and control groups, reproducibility and eVect of medication that have important implications for the use of saccadic latency distributions as biomarkers of disease. Secondly, and perhaps most interestingly, the eVects of L-dopa on reaction time and the decision process with reference to current concepts of the role of dopamine on neural function.
Methods

Subjects
Patients and controls were recruited from the PD research clinic at the Cambridge Centre for Brain Repair. All patients fulWlled UK Brain Bank criteria for the diagnosis of idiopathic PD (with a single subject not meeting one minor criterion) (Gibb and Lees 1988) and were followed up in a specialist setting that has been shown in other studies to provide a positive predictive value for the clinical diagnosis of over 98% (Hughes et al. 2002) . The study was approved by the Local Regional Ethics Committee, and all subjects gave their consent after written and verbal explanation of the procedure, according to the Declaration of Helsinki.
The study involved three groups of subjects (Table 1) : 22 PD patients were recruited from the PD research clinic, forming a heterogeneous group taking a wide range of anti-Parkinsonian medications (the 'PD cross-sectional' group)-there were no exclusions on cognitive or aVective grounds (MMSE range 18-30, BDI range 1-24). A further 15 patients on standard (not slow release) L-dopa monotherapy were selected to participate in the on/oV study (Tables 1 and 2); and Wnally 27 subjects (friend or relatives accompanying patients) with no known neurological disease provided an agematched control population.
Saccade recording equipment
A newly developed head-mounted saccadometer (Ober Consulting, Poznan) was used to present the targets and measure eye movements by changes in the binocular infra-red scleral reXectance (Ober et al. 2003 ). High contrast red target dots were generated from three low-powered lasers that form part of the recording unit. Subjects sat 1.5 m in front of a blank wall, on to which the lasers projected at angles 10° left, 0° or 10° right of centre: to a Wrst approximation these angles are independent of the distance from the subject to the wall. The saccadometer had sensor and output sampling rates of 8 and 1 kHz, respectively, output signal resolution 12 bit, 7% nonlinearity for §30° range, bandwidth 500 kHz, and a noise level between 0.2 and 0.3°. It sits on the bridge of the nose and is held in place by an elastic strap round the head. The device is comfortable and requires no particular skill to set up; because the display moves in synchrony with the head, stabilisation of the head is not necessary. It allows 300 saccadic latencies to be recorded within 15 min, and is automatically calibrated using a small number of preliminary trials.
The latency data was downloaded onto a laptop running LatencyMeter 2.3 (Ober et al. 2003 ) that allowed results from abnormal eye movements to be deleted: saccades in the wrong direction, of abnormal proWle, falling outside the amplitude range 5-15°, or outside the latency range 50-600 ms (arbitrary limits chosen to include express or other early saccades but exclude saccades with prolonged latency due to inattention).
Procedures
Subjects were asked to track the movement of the red laser dot as rapidly as they could. The tracking involved a step task paradigm with no gap or overlap of stimuli: after a random foreperiod (0.5-1 s) the central Wxation target was extinguished as either the left or right target, chosen at random, were turned on, and remained on until a saccade had been performed or for a maximum of 2 s. On 11 out of 79 testing sessions, the number of saccades recorded was less than 300 because of subject fatigue or for technical reasons. Of these 11 cases, over 200 saccades were recorded in eight of the sessions, and over 100 in the remaining three (one from the control group and two from the PD cross-sectional group).
The 15 subjects in the on/oV study group were assessed on two separate occasions; once in the morning after taking their normal morning dose of L-dopa ('on'), and on a separate morning after at least 12 h abstinence ('oV'). Patients were randomised to be tested 'on' before 'oV' L-dopa or vice-versa (Table 2) , and were assessed on each occasion, including the UPDRS (Fahn et al. 1987 ) and Hoehn and Yahr (Hoehn and Yahr 1967) scores. One subject missed their clinical assessment oV medication because of time constraints. Catechol-O-methyl-transferase (COMT) val 158 met and brain derived neurotrophic factor (BDNF) val 66 met polymorphisms were also analysed, given their recently described eVects on some frontostriatal tasks in early PD (Foltynie et al. 2004b .
Reciprobit plots of saccadic latency Saccadic latency, unlike velocity or duration, appears to be controlled at the cortical level, and is highly and randomly variable from trial to trial. However, despite this the distribution of latencies follows a well-deWned law: its reciprocal follows a Gaussian distribution (Carpenter 1981) . Therefore plotting cumulative latency distributions on a probit scale as a function of reciprocal latency (a 'reciprobit plot') yields a straight line (as it would for any such Gaussian distribution), although a small number of early saccades are sometimes seen, which lie on a separate distribution (Carpenter and Williams 1995 ). An example is provided in Fig. 1 : in this case actual latency (not reciprocal) is plotted on a reciprocal axis (analogous to the more commonly used logarithmic axis. Note that for calculations and correlations the reciprocal latency was used-see, for example, Fig. 3 and Table 3 ). This shape of distribution of saccadic latencies is missed if relatively few saccades are recorded or if conventional lumped statistical analysis is used. Importantly, the quantitative parameters of the distribution are directly related to the fundamental parameters of the LATER model (linear approach to threshold with ergodic rate) of decision making.
LATER provides an attractive, testable hypothesis of the decision process that encompasses both the variation seen in saccadic latency distributions and single cell neurophysiological data (recent discussions include Reddi et al. 2003, Reddi and Carpenter 2000) . For example, there are cells within the frontal eye Welds of the monkey Fig. 1 Saccadic latency distribution plotted on reciprobit axes. An example cumulative frequency plot of saccadic latencies is shown, using a probit scale as a function of reciprocal latency: a reciprobit plot. When saccadic latencies are plotted in this way, most points lie on line a, intercepting the inWnite latency axis at an intercept I. In some cases, as here, there may be an additional sub-population of early saccades, which tend to lie on a distinct line b, which passes through the point (inf,50). A change in expectation or urgency causes swivel about the point I, generating a new line of best Wt such as the dashed line c (see text and Reddi et al. 2003) . Three parameters (median latency, main slope, and slope of the early component) are suYcient to characterise the entire distribution whose Wring rate exhibits rise-to-threshold behaviour in advance of a saccade, and whose rate of rise corresponds closely with saccadic latency (Hanes and Schall 1996) .
In terms of decision making the LATER model essentially collects information at a certain rate until there is enough belief in a hypothesis to achieve a threshold criterion level and trigger a response-in this case a saccade (for a discussion, see Reddi et al. 2003) . Over the last decade it has been possible to test the theory by altering the prior probability (Carpenter and Williams 1995) information supply (Reddi et al. 2003 ) and decision criterion level (Reddi and Carpenter 2000) with predictable eVects on the distribution of saccadic latencies, and so far the model has held true. Of particular interest to this study it appears that an increase in the threshold criterion level required before a decision is made results in an anticlockwise swivel of the distribution (Fig. 1 , line of best Wt swivels from a to c) (Reddi and Carpenter 2000) , whereas a change in the rate of information supply causes a parallel shift rather than a swivel of the distribution (Reddi et al. 2003) .
Statistics
Saccadic latencies were analysed using SPIC software (Carpenter 1994 ) after removal of erroneous eye movements. A cumulative reciprobit frequency histogram of saccadic latencies was plotted for each testing session (Carpenter 1988) , and separate trendlines Wtted by the computer through the main population of saccades and the smaller group of early saccades by minimising the Kolmogorov-Smirnov statistic. For each subject the reciprocal median saccadic latency and the slope of the two trendlines were recorded. These three parameters were Gaussian distributed in the population, assessed by the Kolmogorov-Smirnov test, and thus their means were taken to compare groups (Table 3) . Controls were compared to the PD cross-section group with an unpaired two-tailed Student's t test, and the 'on' was compared to the 'oV' L-dopa group with a paired twotailed Student's t test.
The diVerence in distributions of saccadic latencies 'on' and 'oV' L-dopa was analysed using a KolmogorovSmirnov test for each individual, using reciprocal median latency as its distribution is Gaussian, whereas that of latency is highly skewed. The eVect of L-dopa on the reciprobit distributions 'on' and 'oV' L-dopa was assessed using log likelihood comparison: pairs of distributions under the two conditions were jointly Wtted, using a maximum likelihood method, with the alternative constraints of parallel shift, or of swivel of the distribution about a common intercept with the t=1 axis. A log likelihood measure of support for the alternative hypotheses of shift versus swivel was thus obtained for each patient, and summed across all patients to provide an overall measure of support for one rather than the other, diVerences of more than 3 log units being equivalent to a conventional signiWcance criterion of P=0.05. Pearson's product moment correlation coeYcient with two-tailed P value was used to assess the relationship between saccadic and clinical parameters.
Results
All subjects tolerated the new saccadometer extremely well, and example reciprobit plots drawn after the removal of erroneous eye movements are shown in Fig. 2 . The data tend to lie along a straight line with a variable early component, as described previously [ Fig. 1 and (Carpenter and Williams 1995) ], although the median latencies, slope of the main distribution and number and slope of early saccades is very variable between diVerent subjects irrespective of disease status. The 'on/oV' study revealed that the shape of the distribution of latencies was very similar in the two testing sessions, although L-dopa caused a swivel of the distribution in some patients (discussed below).
The three parameters that describe the distribution of saccadic latencies in the diVerent groups are presented in Table 3 . A signiWcant diVerence was found in the reciprocal of the median latencies between subjects 'on' and 'oV' L-dopa, but no other parameters were signiWcantly diVerent between groups (the early slope is only a small proportion of the total saccades).
Intersubject variation: the cross-sectional study
The variation in saccadic latency between subjects was found to be high in all groups, as shown by the broad spread of reciprocal median latencies in Fig. 3 . A statistically signiWcant diVerence was found between the 27 controls and the 15 PD patients tested 'on' medication (t=2.20, df=40, P=0.03), but this was lost when they were 'oV' medication. Furthermore, no signiWcant diVerence was seen between the control group and the 22 PD Fig. 1 ). The magnitude of the eVect varies between subjects. b Three example reciprobit plots from control subjects. There is intersubject variability in median latency and the shape of the distribution varies between subjects. Note that small diVerences in the tails of reciprobit plots have highly visible eVects on their shape despite representing a small proportion of the saccades (P, PD patient codes refer to Table 2 patients comprising the cross-sectional group. These latter patients form a more heterogeneous group than the patients tested on and oV medication; they used a wider variety of anti-Parkinsonian medication, the time between medication and testing was more varied, and some subjects had more advanced disease than the 'on/ oV' group. As has been reported previously, a correlation was seen between age and reciprocal median latency (older PD patients and controls have slower reaction times: r=¡0.35, P=0.01), but no such correlation existed with other patient characteristics such as disease duration, mini mental state examination or gender. Table 1 . When analysed individually, the eVect of L-dopa on saccadic latencies was found to be predominantly due to Wve of the patients showing a statistically signiWcant diVerence in their distribution of saccadic latencies on and oV medication (Fig. 4) . The three patients using antidepressants (Table 2 , patients 6, 9, and 11) were not outliers on Fig. 4 . COMT val 158 met and BDNF val 66 met polymorphisms did not correlate with the eVect of L-dopa on saccadic latencies although the sample size is small. Furthermore, we found no correlation between the eVect of L-dopa on reciprocal median saccadic latencies ('on' minus 'oV' L-dopa) and either the dose of L-dopa (r=¡0.15, P=0.59) or disease severity as assessed by the motor UPDRS 'on' score (r=0.23, P=0.4). In addition, there was no correlation between the L-dopa induced change in reciprocal median latency (on/oV) and the change in UPDRS (r=0.23 P=0.40). A correlation was seen though between the 'on' reciprocal median latency and 'on' motor UPDRS but this was lost 'oV' treatment ('on': r=¡0.55, P=0.03, Fig. 5 ; 'oV': r=¡0.21, P=0.48).
The number of discarded trials was compared in the 'on' and 'oV' state in order to study error responses, although both human and mechanical factors contributed to trials being discarded (see Methods). The percentage of discarded trials was not signiWcantly diVerent 'on' and 'oV' L-dopa (mean § SD% discarded trials 'on'=28.8 §14; 'oV'=32.7 §15, P=0.25). The percentage of discarded trials 'on' medication did not correlate to 'on' reciprocal median latency (r=¡0.42, P=0.12) or dose of L-dopa (r=0.01, P=0.97), but did correlate to the percentage of discarded trials 'oV' L-dopa (r=0.64, P=0.01) .
Likelihood analysis was performed to determine whether the signiWcant slowing eVect of L-dopa acted to cause a parallel shift of the distribution of saccadic latencies or cause the distribution to swivel about the inWnity axis intercept on a reciprobit plot (see Fig. 1 ). The group combined log likelihood for 'swivel' versus 'shift' was 11.2, conWrming with a very high degree of certainty that L-dopa causes anticlockwise swivel of the distributions (Fig. 2 and Table 4 ).
Discussion
The main Wnding of this study is that the distribution of saccadic latencies can be signiWcantly aVected by L-dopa, which tends to slow reaction time, with important implications for the role of dopamine in the neural decision Fig. 3 The intersubject variability in saccadic latency is high in all groups. a Mean § SEM error bars. There is a signiWcant diVerence between the control and 'PD on ' groups (t=2.20, df=40, P=0.03) , and between the 'PD on ' and 'PD oV' groups (t=¡2.15, df=14, P=0.05) . b Latencies of each subject are plotted individually to demonstrate the intersubject variability process. Furthermore, in conjunction with the great intersubject variability of saccadic latency that we observed, this Wnding has important implications for the use of the technique as a biomarker of PD.
Saccadic latency distributions as a biomarker of PD: intersubject variation and reproducibility.
Although in some circumstances we found saccadic latency to be prolonged in PD, this was not uniformly the case (Fig. 3) , although it is broadly in agreement with the majority of manual reaction time data in PD [reviewed by Gauntlett-Gilbert and Brown 1998 ]. Published data on saccadic latency in PD is rather unclear, with results tending to be task-speciWc: 'reXexive' saccadic latencies tend to be unchanged or shorter in PD, whereas 'voluntary' saccadic latencies tend to be prolonged [reviewed in (Briand et al. 1999) ].
Given the intersubject variability and degree of overlap of saccadic latency distributions from PD patients and controls it is clear that as it currently stands this technique could not be used as a diagnostic biomarker of PD-a conclusion compatible with other recent studies involving nondemented PD patients, although these were analysed diVerently (Mosimann et al. 2005) . Nevertheless, saccadic latency does seem to correspond to severity of disease (Fig. 5 ) and the presence of dementia (Mosimann et al. 2005) , suggesting that it might prove to be a useful marker of disease progression-perhaps in particular of cognitive decline. Clearly this requires investigation in longitudinal studies, but recently simple reaction and movement times have shown promise as biomarkers by detecting changes in motor performance over time in patients undergoing embryonic nigral cell transplantation, and correlating with UPDRS 'oV' scores at 4 and 12 months of post-transplantation (Gordon et al. 2004) . Fig. 4 The eVect of L-dopa on saccadic latency distributions: it tends to slow reaction time. a There is a signiWcant diVerence in reciprocal median saccadic latencies on versus oV L-dopa (P=0.05), although it varies between subjects (P1-P15, see Table 2 ). b The KolmogorovSmirnov test showed that subjects 1, 2, 4, 10 and 13 had signiWcantly diVerent median saccadic latencies on and oV L-dopa (P<0.05). The COMT Val 158 Met and BDNF Val 66 Met polymorphism genotype is shown for each subject: V valine; M methionine; a dash indicates that no sample was available. (A full colour version of this Wgure is available online at http://www.dx.doi.org/ 10.1007/s00221-006-0412-z Many factors will aVect intersubject variation (dementia, concentration, medication, and so on), some of which are recorded in Table 1 ; however, each of these parameters requires separate investigation. With this in mind we chose to focus speciWcally on the eVect of L-dopa, and found that it signiWcantly aVected reproducibility (discussed below). From a biomarker perspective such eVects need further investigation, and tend to reduce the power of the marker depending on the magnitude of drug eVect compared, for example, to disease progression. Given the heterogeneity of PD it is likely that we will require diVerent biomarkers to track the development of diVerent cognitive, motor or pathological parameters as they progress at diVerent rates over time. Since 'reXexive' saccadic latency seems to be most prolonged by a combination of cortical and subcortical pathology rather than either in isolation (Mosimann et al. 2005) , one might speculate that analysis of saccadic latency distributions will turn out to be a particularly sensitive biomarker of the onset and progression of cognitive defects and dementia within a PD population (Foltynie et al. 2004a) , and might enable the disease progression to be described according to the LATER decision model.
The eVect of L-dopa on latency distributions
Our observation that L-dopa prolongs saccadic latency is rather surprising given the documented clinical improvement, the observation that manual reaction time is generally shortened by dopaminergic stimulation (Gauntlett-Gilbert and Brown 1998), and our own observation that latency tends to be prolonged in advanced disease (Fig. 5) . However, the reduction in dopamine is one of a number of features of disease progression which could aVect latency. The 'on/oV' study was designed to mitigate interference from factors such as dementia, allowing us to speciWcally investigate the eVect of L-dopa, whilst acknowledging that further study of other variables will be required to fully characterise intersubject variation.
Interestingly, the numerous studies of manual reaction time in PD suggest that the eVect of L-dopa depends on the basal reaction time-if this is slow, the addition of L-dopa has a greater beneWcial eVect (Gauntlett-Gilbert and Brown 1998; Robbins and Brown 1990) . It has been suggested that as the supply of dopamine becomes limited it aVects fast reaction times Wrst, then as the levels fall further slower reaction times become aVected (Robbins and Brown 1990) . It is possible that in our study the L-dopa taken by patients with relatively mild PD may overdose some dopaminergic networks in the brain, exceeding an optimal threshold and resulting in poorer performance (see below).
There are relatively few published studies speciWcally addressing the eVect of dopamine on saccadic reaction times, and a number of methodological concerns hinders their interpretation: the use of diVerent testing procedures, failure to counterbalance 'on' and 'oV' order of testing, diVerent medication and withdrawal regimes, and so on (reviewed critically by Harrison et al. 1995) . Some studies show no eVect of dopaminergic drugs Crevits et al. 2000) , whereas others report broadly beneWcial eVects on latency, gain or amplitude of saccades Rascol et al. 1989; Vermersch et al. 1994) . None have reported the detrimental eVect on saccadic latency we describe here, but there is evidence to suggest that in some circumstances dopamine might have an adverse eVect on manual and saccadic reaction times. It has recently been reported that a simple manual reaction time task is Table 4 Log likelihoods of L-dopa causing a swivel versus a shift in saccadic latency distributions (see Fig. 1) The sum of 11.2 strongly suggests that L-dopa causes a swivel of the distribution of saccadic latencies about the inWnity intercept rather than a parallel shift (a high number favours swivel) , r=¡0.55, P=0.03) delayed in PD patients as a result of subcutaneous apomorphine injection, a D1 and D2 receptor agonist (Muller et al. 2002) , and similarly apomorphine has been reported to impair the reaction time in certain strains of rats (Wilcox and Spirduso 1988) . Amphetamine causes dopamine release and reuptake inhibition, and has been found to prolong saccadic latencies in humans (Dursun et al. 1999) , whereas haloperidol, a dopamine antagonist with mild anticholinergic action, has been found not to aVect saccades (Lynch et al. 1997 ).
The elegance of analysing saccadic latencies using reciprobit plots is that as well as providing more information than is encapsulated in a single parameter such as median or mean, they allow us to directly test the parameters of the LATER model of neural decision making (Carpenter 1981) . In this case the observed anticlockwise swivel of the distributions caused by L-dopa suggests that this medication acts to increase the threshold criterion required before making a decision. In other words, it implies that L-dopa tends to render a subject less impulsive such that they require a higher degree of certainty before making a decision. Given this it might be expected that subjects should make fewer saccadic errors 'on' L-dopa. The analysis of discarded trials did not show a signiWcant diVerence as a result of medication; however, since such errors were more often the result of mechanical displacement of the saccadometer than poor subject performance this may not be surprising.
The site of action of dopamine
The ultimate brain region inXuenced by L-dopa in this instance is not known, but an appealing candidate is the frontal eye Welds, where the Wring rate of single neurons in the monkey show rise-to-threshold behaviour in advance of a saccade that correspond closely with LATER's decision signal (Hanes and Schall 1996) . Furthermore, in primates, D2 receptor activation can modulate the activity of prefrontal neurons to memory-guided saccades (Wang et al. 2004 ). However, neurons encoding a decision signal, with a rise in Wring frequency preceding movement, are widely distributed in the brain and may be the result of integration of signals routed through positive feedback loops via the basal ganglia or thalamus (Romo and Schultz 1987; Romo and Schultz 1992) . Neurophysiological evidence of a decision signal has also been found, for example, in the dorsolateral prefrontal cortex (Kim and Shadlen 1999) , posterior pariental cortex (Shadlen and Newsome 1996) and superior colliculus (Horwitz et al. 2004; McCoy and Platt 2005; Schall 1999) . It is therefore not clear that it makes much sense to talk about the 'site' of a decision process, when decisions appear rather to be the result of a distributed network of neurons covering a wide area of the brain. Furthermore, dopamine has a well-described central sedative eVect (Micallef-Roll et al. 2001 ) as well as a peripheral eVect on the retina (Djamgoz et al. 1997 ), but we would not expect to see the same swivel in latency distributions if these eVects constituted its primary mode of action here.
Since the 1980s it has been appreciated that dopamine can worsen some cognitive functions whilst improving others (Gotham et al. 1988) , and there is evidence for a number of frontostriatal circuits that can be diVerentially aVected by dopamine. In particular, it seems that tests of neuropsychological function relating to the dorsolateral prefrontal cortex improve with dopamine, whereas ventrolateral and orbitofrontal functions deteriorate (Cools et al. 2001 (Cools et al. , 2003 Swainson et al. 2000) . Here, however, although there are cells within the frontal eye Welds that seem to represent a saccadic decision, this area (Brodmann area 8) is closest to the dorsal stream (Brodmann areas 9, 46), and the slowing of saccadic latencies in response to L-dopa is unlikely to be explained by this hypothesis.
However, the relationship between prefrontal and nigrostriatal dopamine levels is complex such that in early PD the midbrain dopamine deWciency is accompanied by a more generalised prefrontal excess of dopamine. Thus the administration of L-dopa may 'overdose' this area to the extent that performance on cognitive tasks relating to this region deteriorates-in an inverted U-shaped "Yerkes-Dodson" manner (Williams and Goldman-Rakic 1995; Foltynie et al. 2004b) . Rather than the dorsal-ventral diVerential eVect of dopamine described above this theory proposes a cortical-subcortical division, and therefore might explain the deterioration in function of the frontal eye Welds (and therefore prolonged saccadic latencies) in response to excess dopamine. In particular, polymorphisms in both COMT and BDNF genes have been associated with variable prefrontal function in diVerent people, an observation explained in terms of their eVect on basal dopamine levels (Foltynie et al. 2004b Meyer-Lindenberg et al. 2005) . In this study, however, there was no association between COMT or BDNF genotypes and the eVect of L-dopa on saccadic latencies, although larger numbers of patients are required to fully address this issue.
Finally, it is possible that the eVect of dopamine might not be explained by either of the above hypotheses, and may instead relate to deterioration in function not of the frontal eye Welds, but of the parietal eye Welds. Indeed a recent review has highlighted the predominant role of the parietal eye Weld in 'reXexive' saccades, and the frontal eye Welds in 'voluntary' saccades (Leigh and Kennard 2004) . In particular, parietal eye Weld lesions in humans cause increased latency of visually triggered saccades, which does not seem to occur after frontal eye Weld lesions (Pierrot-Deseilligny et al. 1991; Braun et al. 1992) . Furthermore, lesion of the parieto-collicular tract can cause isolated impairment of reXexive but not memory-guided saccades (Gaymard et al. 2003 ). As discussed above, single cell recordings are compatible with decision units in this region (Shadlen and Newsome 1996) . Thus, the exact site of action of L-dopa in the control of saccadic eye movements is not clear at present, and requires further research. Intriguingly, it might be that excess dopamine is detrimental to parietal as well as frontal lobe function. However, it should be stressed that the division of saccades into 'reXexive' and 'voluntary' is not absolutethe task we used is neither a purely reXexive task (requiring identical responses across all trials) nor truly voluntary such as memory-guided saccades or antisaccades.
It is clear that dopamine can have diverse eVects on diVerent functions of the brain that may or may not be anatomically distinct. An increased level following L-dopa administration can, under certain circumstances, improve performance on some tasks (bradykinesia, simple manual reaction time, neuropsychological function relating to the dorsolateral prefrontal cortex), but worsen others (neuropsychological function relating to the ventrolateral prefrontal cortex, saccadic latency as described here). The eVect on reaction times seems to be dependent on the testing paradigm (simple 'reXexive' reaction time versus 'voluntary' or choice reaction time), and the dopaminergic tone, which in turn depends on the severity of PD, the dose of replacement therapy and the timing of subsequent testing. A dissociation between voluntary saccadic latency and manual reaction time has already been shown in the monkey following local depletion of dopamine in the caudate nucleus, albeit with prolongation of saccadic latency in this case (Kori et al. 1995) . Careful analysis of saccadic latencies and manual reaction times in humans in response to diVerent testing paradigms will shed further light on the relationship between these variables and the role of dopamine in the decision process.
In summary two primary conclusions can be made from this study. Firstly, saccadic latency distributions show great intersubject variability and are therefore unable to provide much help in PD diagnosis. However, longitudinal studies looking at intrasubject variation (reproducibility) over time compared to the eVect of medication are required to determine whether the technique might ultimately turn out to be a useful biomarker of disease progression. Secondly, we have shown that L-dopa aVects the distribution of saccadic latencies, and propose that this occurs because it increases the threshold criterion level of evidence required before a decision to move is made. The site of this eVect and the decision process is not currently known, and may be diVuse, involving interaction of a number of cortical and subcortical regions of the brain.
